CIPO

(redirected from Canadian Intellectual Property Office)
Also found in: Wikipedia.
AcronymDefinition
CIPOCanadian Intellectual Property Office
CIPOConsejo Indigena Popular de Oaxaca (Spanish; indigenous organization; Oaxaca, Mexico)
CIPOChief Intellectual Property Officer
CIPOCanadian Immunodeficiencies Patient Organization
CIPOCINC Interoperability Program Office
CIPOCritical Infrastructure Protection Officer
References in periodicals archive ?
Tiomin Resources Inc.'s patent application for processing in the production of synthetic rutile was approved by the Canadian Intellectual Property Office.
Cantor Fitzgerald analyst Elemer Piros notes that PolarityTE was granted a patent by the Canadian Intellectual Property Office related to methods for development and use of minimally polarized function cell micro-aggregate units.
The Canadian Intellectual Property Office is pleased to announce that the new Patent Rules were published today in the Canada Gazette, Part II.
Oxford BioDynamics plc (LSE: OBD) has been granted a patent by the Canadian Intellectual Property Office covering its technology platform, EpiSwitch, the biotechnology company revealed on Thursday.
In another report by Thomson Reuters, an analysis of data gleaned from the Canadian Patents Database of the Canadian Intellectual Property Office shows a significant decrease in the number of patent applications (having Canadian priority) that have been filed over the past decade.
The earlier TMT patent (TMT1) is in process of prosecution at the Canadian Intellectual Property Office.
For several years, it has been possible to patent subject matter in the United States that the Canadian Intellectual Property Office has refused to recognize as patentable subject matter.
The Canadian Intellectual Property Office issued the notice of allowance after a conflict proceeding was resolved in Enzo's favor.
It will allow Canada to better participate in the global IP system, positioning the Canadian Intellectual Property Office (CIPO) as a premier international trademark office and advancing our collaboration with the World Intellectual Property Organization (WIPO), which administers the treaties.
IntelGenx announced that the Canadian Intellectual Property Office recently issued a Notice of Allowance for the Company's Canadian Patent Application Number 2,998,223 entitled "Loxapine Film Oral Dosage Form", covering the use of loxapine in an oral transmucosal film for the treatment of schizophrenia or bipolar 1 disorder.
This patent, effective until 9 May 2022, was awarded by the Canadian Intellectual Property Office.
He currently resides in Ottawa, ON, and works as a patent examiner in the chemical division of the Canadian Intellectual Property Office, an agency of Industry Canada.
Full browser ?